Informatie:
Fout:
ID
38025
Beschrijving
Effectiveness and Toxicity of Gemcitabine/Lobaplatin Versus Gemcitabine/Cisplatin as Second-line Treatment in Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01483300
Link
https://clinicaltrials.gov/show/NCT01483300
Trefwoorden
Versies (1)
- 09-09-19 09-09-19 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
9 september 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT01483300
Eligibility Breast Cancer NCT01483300
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT01483300
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Secondary malignant neoplasm of female breast
Item
histologically confirmed metastatic breast cancer
boolean
C0346993 (UMLS CUI [1])
Disease Progression During First line Prior Chemotherapy | Disease Progression Post First line Prior Chemotherapy
Item
disease progression during or after previous 1st line chemotherapy
boolean
C0242656 (UMLS CUI [1,1])
C0347984 (UMLS CUI [1,2])
C1708063 (UMLS CUI [1,3])
C1514457 (UMLS CUI [1,4])
C0242656 (UMLS CUI [2,1])
C0687676 (UMLS CUI [2,2])
C1708063 (UMLS CUI [2,3])
C1514457 (UMLS CUI [2,4])
C0347984 (UMLS CUI [1,2])
C1708063 (UMLS CUI [1,3])
C1514457 (UMLS CUI [1,4])
C0242656 (UMLS CUI [2,1])
C0687676 (UMLS CUI [2,2])
C1708063 (UMLS CUI [2,3])
C1514457 (UMLS CUI [2,4])
Second line Chemotherapy Scheduled
Item
scheduled to receive 2nd line chemotherapy.
boolean
C1710038 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])
C0392920 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])
Measurable Disease | Lesion Quantity Measurable Linear
Item
measurable disease, defined as a least one lesion that can be accurately measured in at least one dimension
boolean
C1513041 (UMLS CUI [1])
C0221198 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1513040 (UMLS CUI [2,3])
C0205132 (UMLS CUI [2,4])
C0221198 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1513040 (UMLS CUI [2,3])
C0205132 (UMLS CUI [2,4])
Age
Item
18 years of age or older
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status of 0-2
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy of greater than 6 months
boolean
C0023671 (UMLS CUI [1])
Prior Therapy Investigational New Drug
Item
previous treatment with one of the study drugs
boolean
C1514463 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,2])
Cytotoxic Chemotherapy | Therapeutic radiology procedure
Item
application of other cytotoxic chemotherapy or radiotherapy
boolean
C0677881 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C1522449 (UMLS CUI [2])
Renal function Insufficient | Creatinine clearance measurement
Item
insufficent renal function (creatinine clearance < 60ml/min)
boolean
C0232804 (UMLS CUI [1,1])
C0231180 (UMLS CUI [1,2])
C0373595 (UMLS CUI [2])
C0231180 (UMLS CUI [1,2])
C0373595 (UMLS CUI [2])
Metastatic malignant neoplasm to brain Clinical Unstable
Item
clinically unstable brain metastasis
boolean
C0220650 (UMLS CUI [1,1])
C0205210 (UMLS CUI [1,2])
C0443343 (UMLS CUI [1,3])
C0205210 (UMLS CUI [1,2])
C0443343 (UMLS CUI [1,3])
Pregnancy | Breast Feeding
Item
pregancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Cancer Other
Item
history of other malignancy within last 5 years.
boolean
C1707251 (UMLS CUI [1])